Emedonline: Telemedicine Medication Management System

Emedonline：远程医疗用药管理系统

• 批准号: 6644405
• 负责人: Barbara Ann Rapchak
• 金额: $ 10万
• 依托单位: LEAP OF FAITH TECHNOLOGIES, INC.
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-08-01 至 2004-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6644405
• 关键词: chemotherapy; clinical research; drug administration rate /duration; human old age (65+); human subject; hypertension; self medication; technology /technique development; telemedicine; therapy compliance; chemotherapy; clinical research; drug administration rate /duration; human old age (65+); human subject; hypertension; self medication; technology /technique development; telemedicine; therapy compliance

DESCRIPTION (provided by investigator): Medication non-compliance is estimated to cost the US healthcare system an estimated $76.6 billion a year. Approximately 10% of hospital admissions are related to medication issues, costing up to $50 billion annually. Understanding the causes of noncompliance and identifying methods to help patients follow their regimens may improve health outcomes and reduce related costs. We propose to determine whether a medication management system improves compliance among elderly patients being treated for hypertension. The medication management system, called Emedonline, uses standard cellular phone technology to call patients at programmed intervals, gives voice, text, and graphic instructions for taking prescribed medications, and dispenses the medications. It focuses specifically on modifying social interaction factors and providing a tool to enhance the administration process. We have identified three key objectives toward achieving Phase I and Phase II goals: 1. Develop Emedonline to facilitate prescribing medication regimens for healthcare providers, and facilitate medication compliance for patients. 2. Assess the acceptability of the service among healthcare providers, pharmacists, and patients. 3. Evaluate effects on medication compliance, perceived social support, and feelings of control over health destiny. During Phase I, we will examine requirements through focus groups with a sample of healthcare providers, pharmacists, and patients; develop a prototype of the Emedonline system; conduct a concept test with the sample; and create detailed specifications for Phase II development.

描述（调查人员提供）：估计不合规的药物不合规会使美国医疗保健系统每年造成766亿美元。 大约10％的医院入院与药物问题有关，每年耗资高达500亿美元。 了解不遵守规定的原因和确定帮助患者遵循其方案的方法可以改善健康结果并降低相关成本。 我们建议确定药物管理系统是否改善了接受高血压治疗的老年患者的依从性。药物管理系统称为EMEDONLINE，使用标准的蜂窝电话技术以编程的间隔为患者打电话，提供了服用处方药的语音，文字和图形说明，并分配了药物。它专门针对修改社会互动因素，并提供一种工具来增强管理过程。 我们已经确定了实现第一阶段和第二阶段目标的三个关键目标：1。开发EMEDONLINE以促进医疗保健提供者处方药物方案，并促进患者的药物依从性。 2。评估医疗保健提供者，药剂师和患者中服务的可接受性。 3。评估对药物依从性的影响，感知的社会支持以及对健康命运的控制感。 在第一阶段，我们将通过焦点小组与医疗保健提供者，药剂师和患者的样本进行研究；开发EMEDONLINE系统的原型；对样品进行概念测试；并为第二阶段开发创建详细的规格。